DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	1

告示番号

疾患名（ページ内リンク）

臨床試験数

肺動脈性肺高血圧症

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00454207 (ClinicalTrials.gov)	April 2007	28/3/2007	Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension	A Phase 3, Multi-Center, Open-Label Study to Assess Safety and Efficacy of Sildenafil Citrate 20 mg TID in Subjects With Pulmonary Arterial Hypertension	Pulmonary Hypertension	Drug: sildenafil citrate (UK-92,480)	Pfizer	NULL	Completed	16 Years	N/A	All	44	Phase 3	Japan

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00454207
(ClinicalTrials.gov)

April 2007

28/3/2007

Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension

A Phase 3, Multi-Center, Open-Label Study to Assess Safety and Efficacy of Sildenafil Citrate 20 mg TID in Subjects With Pulmonary Arterial Hypertension

Pulmonary Hypertension

Drug: sildenafil citrate (UK-92,480)

Pfizer

NULL

Completed

16 Years

N/A

All

Phase 3

Japan